Skip to main content

Table 2 Cardiac dimensions, function and glucose metabolism

From: Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

 

T2DM (n = 78)

Controls (n = 14)

P value

Rate pressure product ((beats/min)mmHg)

8503 ± 1458

7096 ± 1531

0.005

Distensibility aorta ascendens (10-3mmHg-1)

3.13 (2.29-5.95)

5.63 (4.50-8.07)

0.008

LV mass (g)

107.3 ± 16.7*

111.7 ± 24.4

0.42

LV enddiastolic volume (mL)

154 (134-174)

180 (159-210)

0.002

LV end-systolic volume (mL)

59 (52-71)*

72 (63-82)

0.001

LV mass/volume ratio (g/mL)

0.70 ± 0.11

0.63 ± 0.09

0.05

Stroke volume (mL)

94 ± 16*

107 ± 23

0.002

LV ejection fraction (%)

60 ± 6*

59 ± 4

0.35

E peak filling rate (mL/s)

417 ± 84*

503 ± 112

< 0.001

E deceleration peak (mL/s2 10-3)

3.40 (2.89-3.99)*

4.73 (3.11-5.19)

0.003

E/A peak ratio

1.04 ± 0.25*

1.26 ± 0.36

0.01

E/Ea

9.3 (7.0-11.7)

8.7 (6.4-10.8)

0.34

MBF (mL/g/min)

0.84 (0.75-0.96)

0.88 (0.77-1.01)

0.8

MMRglu (nmol/mL/min)

257 ± 130

348 ± 154

0.02

  1. *Adapted from Rijzewijk et al. [2]. Data are represented as means ± SD or as median (interquartile range). LV: left ventricular; E/A: ratio of peak filling rates of the early filling phase and arterial contraction; E/Ea: estimated LV filling pressures; MBF: myocardial blood flow; MMRglu: myocardial metabolic rate of glucose uptake.